(NaturalHealth365) Scientist are reporting what could be a giant set back in the race for a cancer cure. Customized cancer treatments based on each person’s genes was to be the newest way to conquer cancer.
Doctors have been offering genetic testing to patients for several years, and have pinned their hopes on finding the needle in the haystack.
There is a database of results on nearly 4,000 tumor samples. So far 40 percent of breast cancers have discrepancies between which genes are active in the main tumor and which ones are active where the cancer has spread.
Also, the scientists have discovered big differences from place to place in the same tumor as to which genes are active or mutated. This means the single biopsies, which doctors rely on to choose drugs are probably not giving them the information to make an informed choice.
This muddled picture gives researches no clue on how to individualize treatment. There are about 15 medicines on the market now and hundreds in the pipe lines, but so far they have had very limited success. The logical conclusion is this testing will fail to save lives.
Healthcare costs skyrocket and offer no help
It costs 5,000 to 10,000 to do basic gene analysis of the main tumor, and about 10 times as much to do the kind of testing that these scientists did.
Studies show that the single biopsy, which is the cornerstone of personalized-medicine decisions, and the view that you can direct therapy on the basis of genetic tumor markers, is too simple.
The single biopsy would reveal only a minority of mutations. The tumor can adapt to cancer medicines, even the ones that are specific. The cancer industry has no idea if doing more biopsies would improve accuracy, or how many or how often they should be done.
Dr. Gordon Mills, co-director of the Institute for Personalized Cancer Therapy knows this is important. This is the problem as he sees it; in the future scientist will find out a lot of information and will not know what to do with it.
“There will be times when one biopsy suggests a certain mutation is driving the cancer and another biopsy suggest a different one is.”
Genetic Testing is witnessing a period of profound growth; let’s say in the $10 billion dollar range. Phamacogenomics is the most lucrative segment of genetic testing. With the rising number of cancer patients it is expected that genetically tailored personalized drugs will grow rapidly over the next few years along with your cancer.
A better way
Epigenetic is the science that tells us all genes either turn on or off based on their environment. Lifestyle choices have been shown to be the most effective way in preventing and reversing cancer. Currently, many holistic doctors are curing people of cancer for a fraction of the cost with no deadly side effects.
The continual failure of modern medicine is forcing people to look elsewhere for answers. When enough people demand something better from their healthcare provider medicine will have to respond.
About the author Blanche has been a student of natural healing modalities for the last 25 years. She had the privilege of working with some of the greatest minds in Natural Healing including Naturopaths, Scientist, and Energy Healers. Having seen people miraculously heal from all kinds of dies-ease through non-invasive methods, her passion now is to help people become aware of what it takes to be healthy.